Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Affective Disorder | Research article

Co-morbidities of mental disorders and chronic physical diseases in developing and emerging countries: a meta-analysis

Authors: Labanté Outcha Daré, Pierre-Emile Bruand, Daniel Gérard, Benoît Marin, Valerie Lameyre, Farid Boumédiène, Pierre-Marie Preux

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

As the data on the association of mental disorders and chronic physical diseases in developing and emerging countries is heterogeneous, this study aims to produce the first meta-analysis of these comorbidities.

Methodology

The meta-analysis protocol was registered in PROSPERO (N°CRD42017056521) and was performed in accordance with PRISMA guidelines. Initially, an article search was conducted on Medline, Embase, Lilacs and the Institut d’Epidémiologie et de Neurologie Tropicale database [Institute of Epidemiology and Tropical Neurology], as well as manually, with no restriction on language or date focusing on mental disorders, chronic diseases and neurotropic diseases. Two independent investigators assessed the quality of the studies which met the inclusion criteria using the Downs and Black assessment grid. The pooled estimates were calculated out using a random-effects method with CMA software Version 3.0. A meta-regression was then performed, and the significance level was set at 0.05.

Results

Of the 2604 articles identified, 40 articles involving 21,747 subjects met the inclusion criteria for co-morbidities between mental disorders and chronic physical diseases. Thirty-one articles were included in the meta-analysis of prevalence studies and 9 articles in that of the analytical studies. The pooled prevalence of mental disorders in patients with chronic physical diseases was 36.6% (95% CI, 31.4–42.1) and the pooled odds ratio was 3.1 (95% CI, 1.7–5.2). There was heterogeneity in all the estimates and in some cases, this was explained by the quality of the studies.

Conclusion

Some estimates regarding the prevalence of mental disorders in people with chronic physical diseases living in developing and emerging countries were similar to those in developed countries. Mental disorders are a burden in these countries. In order to respond effectively and efficiently to the morbidity and mortality associated with them, mental health care could be integrated with physical care.
Appendix
Available only for authorised users
Literature
1.
Thornicroft G, Votruba N. Millennium development goals: lessons for global mental health. Epidemiol Psychiatr Sci. 2015;24:458–60.PubMedCrossRef
2.
Thornicroft G, Votruba N, Baingana F, Bhugra D, Eaton J, Goetzke K, Gureje O, Ivbijaro G, Lamichhane J, Lund C, et al. Millennium development goals: lessons for global mental health. Epidemiol Psychiatr Sci. 2014;24:458–60.CrossRef
3.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1545–602.CrossRef
4.
Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (London, England). 2013;382:1575–86.CrossRef
5.
Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry. 2016;3:171–8.PubMedCrossRef
6.
Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004;291:2616–22.PubMedCrossRef
7.
8.
9.
10.
11.
12.
World Health Organization: 10 facts on non-communicable diseases. 10 faits sur les maladies non transmissibles. Accessed 23 Apr 2017.
13.
14.
Nakash O, Levav I, Aguilar-Gaxiola S, Alonso J, Andrade LH, Angermeyer MC, Bruffaerts R, Caldas-de-Almeida JM, Florescu S, de Girolamo G, et al. Comorbidity of common mental disorders with cancer and their treatment gap: findings from the world mental health surveys. Psycho-Oncology. 2014;23:40–51.PubMedCrossRef
15.
16.
Alves FMB, Coutinho MSSA, Sakae TM, Cosentino MB. Cardiovascular risk factors in patients with non-coronarian atherosclerotic disease in hospital in the South of Brazil: case-control study. Rev Soc Bras Clin Med. 2009;7:3–10.
17.
Al-Hayek AA, Robert AA, Alzaid AA, Nusair HM, Zbaidi NS, Al-Eithan MH, Sam AE. Association between diabetes self-care, medication adherence, anxiety, depression, and glycemic control in type 2 diabetes. Saudi Med J. 2012;33:681–3.PubMed
18.
Danna SM, Graham E, Burns RJ, Deschênes SS, Schmitz N. Association between depressive symptoms and cognitive function in persons with diabetes mellitus: a systematic review. PLoS One. 2016;11:e0160809.PubMedPubMedCentralCrossRef
19.
20.
Mejía-Arango S, Zúñiga-Gil C. Diabetes mellitus as a risk factor for dementia in the Mexican elder population. Rev Neurol. 2011;53:397–405.PubMed
21.
Esposito M, Gallai B, Roccella M, Marotta R, Lavano F, Lavano SM, Mazzotta G, Bove D, Sorrentino M, Precenzano F, et al. Anxiety and depression levels in prepubertal obese children: a case-control study. Neuropsychiatr Dis Treat. 2014;10:1897–902.PubMedPubMedCentral
22.
Yohannes AM, Müllerová H, Hanania NA, Lavoie K, Tal-Singer R, Vestbo J, Rennard SI, Wouters EFM. Long-term course of depression trajectories in patients with COPD: a 3-year follow-up analysis of the evaluation of COPD longitudinally to identify predictive surrogate endpoints cohort. Chest. 2016;149:916–26.PubMedCrossRef
23.
Zhang MWB, Ho RCM, Cheung MWL, Fu E, Mak A. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2011;33:217–23.PubMedCrossRef
24.
25.
Aydin IO, Uluşahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry. 2001;23:77–83.PubMedCrossRef
26.
Asghar S, Hussain A, Ali SMK, Khan AKA, Magnusson A. Prevalence of depression and diabetes: a population-based study from rural Bangladesh. Diabet Med. 2007;24:872–7.PubMedCrossRef
27.
Doherty AM, Gaughran F. The interface of physical and mental health. Soc Psychiatry Psychiatr Epidemiol. 2014;49:673–82.PubMedCrossRef
28.
Mbewe EK, Uys LR, Birbeck GL. The impact of a short depression and anxiety screening tool in epilepsy Care in Primary Health Care Settings in Zambia. Am J Trop Med Hyg. 2013;89:873–4.PubMedPubMedCentralCrossRef
29.
Aillon J-L, Ndetei DM, Khasakhala L, Ngari WN, Achola HO, Akinyi S, Ribero S. Prevalence, types and comorbidity of mental disorders in a Kenyan primary health Centre. Soc Psychiatry Psychiatr Epidemiol. 2014;49:1257–68.PubMedCrossRef
30.
Blakemore A, Dickens C, Guthrie E, Bower P, Kontopantelis E, Afzal C, Coventry PA. Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2014;9:501–12.PubMedPubMedCentralCrossRef
31.
32.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.PubMedCrossRef
33.
34.
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377–84.PubMedPubMedCentralCrossRef
35.
36.
Borenstein M, Larry VH, Julian PTH, Hannah RR. Introduction to Meta-Analysis. Oxford: Wiley; 2009.CrossRef
37.
Boyle MH. Guidelines for evaluating prevalence studies. Evid Based Ment Health. 1998;1:37–9.CrossRef
38.
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1:97–111.CrossRefPubMed
39.
Borenstein M, Larry VH, Julian PTH, Hannah RR. Introduction to forest plots. Oxford: Wiley; 2009.
40.
41.
Aghanwa HS, Erhabor GE. Specific psychiatric morbidity among patients with chronic obstructive pulmonary disease in a Nigerian general hospital. J Psychosom Res. 2001;50:179–83.PubMedCrossRef
42.
Akena D, Kadama P, Ashaba S, Akello C, Kwesiga B, Rejani L, Okello J, Mwesiga EK, Obuku EA. The association between depression, quality of life, and the health care expenditure of patients with diabetes mellitus in Uganda. J Affect Disord. 2015;174:7–12.PubMedCrossRef
43.
Akyol M, Ulger E, Alacacioglu A, Kucukzeybek Y, Yildiz Y, Bayoglu V, Gumus Z, Yildiz I, Salman T, Varol U, et al. Sexual satisfaction, anxiety, depression and quality of life among Turkish colorectal cancer patients [Izmir oncology group (IZOG) study]. Jpn J Clin Oncol. 2015;45:657–64.PubMedCrossRef
44.
Alacacioglu A, Binicier O, Gungor O, Oztop I, Dirioz M, Yilmaz U. Quality of life, anxiety, and depression in Turkish colorectal cancer patients. Support Care Cancer. 2010;18:417–21.PubMedCrossRef
45.
Al-Amer RM, Sobeh MM, Zayed AA, Al-Domi HA. Depression among adults with diabetes in Jordan: risk factors and relationship to blood sugar control. J Diabetes Complicat. 2011;25:247–52.PubMedCrossRef
46.
Alexander PJ, Dinesh N, Vidyasagar MS. Psychiatric morbidity among cancer patients and its relationship with awareness of illness and expectations about treatment outcome. Acta Oncologica (Stockholm, Sweden). 1993;32:623–6.CrossRef
47.
Asnaashari AMH, Talaei A, Haghigh B. Evaluation of psychological status in patients with asthma and COPD. Iran J Allergy Asthma Immunol. 2012;11:65–71.PubMed
48.
Atesci FC, Baltalarli B, Oguzhanoglu NK, Karadag F, Ozdel O, Karagoz N. Psychiatric morbidity among cancer patients and awareness of illness. Support Care Cancer. 2004;12:161–7.PubMedCrossRef
49.
Eslami B, Sundin O, Macassa G, Khankeh HR, Soares JJF. Anxiety, depressive and somatic symptoms in adults with congenital heart disease. J Psychosom Res. 2013;74:49–56.PubMedCrossRef
50.
Fanger PC, Azevedo RCS, Mauro MLF, Lima DD, Gaspar KC, Silva VF, Nascimento WTJ, Botega NJ. Depression and suicidal behavior of cancer inpatients: prevalence and associated factors. Revista Da Associacao Medica Brasileira (1992). 2010;56:173–8.CrossRef
51.
Galeano MT. Depressive indicators in a sample of patients with obesity. Eureka (Asunción, En LíneaEureka). 2011;8:254–66.
52.
Gomes FA, Almeida KM, Magalhaes PV, Caetano SC, Kauer-Sant'Anna M, Lafer B. F: cardiovascular risk factors in outpatients with bipolar disorder: a report from the Brazilian research network in bipolar disorder^ien. Rev Bras Psiquiatr. 2013;35:126–30.PubMedCrossRef
53.
Hamdan-Mansour AM, Al Abeiat DD, Alzoghaibi IN, Ghannam BM, Hanouneh SI. Psychosocial and sociodemographic correlates of life satisfaction among patients diagnosed with cancer in Jordan. J Cancer Educ. 2015;30:31–6.PubMedCrossRef
54.
Hong JS, Tian J. Prevalence of anxiety and depression and their risk factors in Chinese cancer patients. Support Care Cancer. 2014;22:453–9.PubMedCrossRef
55.
Huang Y, Chen J, Yang J, Song K, Wang X, Cheng X, Qu S. Evaluation of depressive symptoms in obese patients with or without acanthosis nigricans. Hormones (Athens, Greece). 2015;14:417–24.
56.
Islam SMS, Ferrari U, Seissler J, Niessen L, Lechner A. Association between depression and diabetes amongst adults in Bangladesh: a hospital based case-control study. J Glob Health. 2015;5:020406.PubMedPubMedCentralCrossRef
57.
Karakurt P, Ünsal A. Fatigue, anxiety and depression levels, activities of daily living of patients with chronic obstructive pulmonary disease. Int J Nurs Pract. 2013;19:221–31.PubMedCrossRef
58.
Khamseh ME, Baradaran HR, Rajabali H. Depression and diabetes in Iranian patients: a comparative study. Int J Psychiatry Med. 2007;37:81–6.PubMedCrossRef
59.
Kirkil G, Deveci F, Deveci SE, Atmaca M. Anxiety and depression symptoms in patients with chronic obstructive pulmonary disease (copd). Klinik Psikofarmakoloji Bulteni. 2015;25:151–61.CrossRef
60.
Li A. Analyses on the rate and epidemic characteristics of anxiety and depression among cancer patients in Yangpu District in Shanghai. Asian Pac J Cancer Prev. 2009;10:895–8.PubMed
61.
Lou P, Chen P, Zhang P, Yu J, Wang Y, Chen N, Zhang L, Wu H, Zhao J. Effects of smoking, depression, and anxiety on mortality in COPD patients: a prospective study. Respir Care. 2014;59:54–61.PubMedCrossRef
62.
Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N, Chen N, Zhang L, Wu H, Zhao J. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med. 2012;12:53.PubMedPubMedCentralCrossRef
63.
Maia ACCO, Braga AA, Brouwers A, Nardi AE, Oliveira e Silva AC. Prevalence of psychiatric disorders in patients with diabetes types 1 and 2. Compr Psychiatry. 2012;53:1169–73.PubMedCrossRef
64.
Maneeton B, Maneeton N, Mahathep P. Prevalence of depression and its correlations: a cross-sectional study in Thai cancer patients. Asian Pac J Cancer Prev. 2012;13:2039–43.PubMedCrossRef
65.
Mehta JR, Ratnani IJ, Dave JD, Panchal BN, Patel AK, Vala AU. Association of psychiatric co-morbidities and quality of life with severity of chronic obstructive pulmonary disease. East Asian Arch Psychiatr. 2014;24:148–55.
66.
Mollaoglu H, Ucok K, Kaplan A, Genc A, Mayda H, Guzel HI, Sener U, Uygur E, Ozbulut O. Association analyses of depression, anxiety, and physical fitness parameters in Turkish obese adults. J Back Musculoskelet Rehabil. 2012;25:253–60.PubMedCrossRef
67.
Morsi TS, Ghobashy S, Younis G. Quality of life and psychological disorders in Egyptian patients with chronic lung diseases: Clinico-physiological correlation. Egypt J Chest Dis Tuberc. 2014;63:731–43.CrossRef
68.
Negi H, Sarkar M, Raval AD, Pandey K, Das P. Presence of depression & its risk factors in patients with chronic obstructive pulmonary disease. Indian J Med Res. 2014;139:402–8.PubMedPubMedCentral
69.
Pandey M, Devi N, Thomas BC, Kumar SV, Krishnan R, Ramdas K. Distress overlaps with anxiety and depression in patients with head and neck cancer. Psycho-Oncology. 2007;16:582–6.PubMedCrossRef
70.
Peltzer K, Pengpid S. Anxiety and depressive features in chronic disease patients in Cambodia, Myanmar and Vietnam. S Afr J Psychiatry. 2016;22:1–4.
71.
Priscilla D, Hamidin A, Azhar MZ, Noorjan KON, Salmiah MS, Bahariah K. Assessment of depression and anxiety in haematological cancer patients and their relationship with quality of life. East Asian Arch Psych. 2011;21:108–14.
72.
Rosrita NN, Yunus F, Ginting TT, Nurwidya F. Depression in patients with stable chronic obstructive pulmonary disease: a cross-sectional study in the national center for respiratory diseases in Indonesia. Pneumologia (Bucharest, Romania). 2016;61:92–6.
73.
Stolic RV, Trajkovic GZ, Mihailovic B, Sipic MV, Celic DB, Lazic SF, Nikolic GR, Sovtic SR, Stolic DZ. Characteristics of depression in obese people living in an insecure environment. Indian J Med Sci. 2010;64:307–14.PubMedCrossRef
74.
Subashini R, Deepa M, Padmavati R, Thara R, Mohan V. Prevalence of diabetes, obesity, and metabolic syndrome in subjects with and without schizophrenia (CURES-104). J Postgrad Med. 2011;57:272–7.PubMedCrossRef
75.
Sweileh WM, Dalal SA, Zyoud SH, Al-Jabi SW, Al-Ali I. Diabetes mellitus in patients with schizophrenia in West-Bank, Palestine. Diabetes Res Clin Pract. 2013;99:351–7.PubMedCrossRef
76.
Tavoli A, Mohagheghi MA, Montazeri A, Roshan R, Tavoli Z, Omidvari S. Anxiety and depression in patients with gastrointestinal cancer: does knowledge of cancer diagnosis matter? BMC Gastroenterol. 2007;7:28.PubMedPubMedCentralCrossRef
77.
Tuncay T, Musabak I, Gok DE, Kutlu M. The relationship between anxiety, coping strategies and characteristics of patients with diabetes. Health Qual Life Outcomes. 2008;6:79.PubMedPubMedCentralCrossRef
78.
Yildirim A, Hacihasanoǧlu Aşilar R, Bakar N, Demir N. Effect of anxiety and depression on self-care agency and quality of life in hospitalized patients with chronic obstructive pulmonary disease: a questionnaire survey. Int J Nurs Pract. 2013;19:14–22.PubMedCrossRef
79.
Zhang J, Ye M, Huang H, Li L, Yang A. Depression of chronic medical inpatients in China. Arch Psychiatr Nurs. 2008;22:39–49.PubMedCrossRef
80.
Zhao L, Li X, Zhang Z, Song C, Guo C, Zhang Y, Zhang Y, Li L, Lu G, Zheng G, et al. Prevalence, correlates and recognition of depression in Chinese inpatients with cancer. Gen Hosp Psychiatry. 2014;36:477–82.PubMedCrossRef
81.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–78.PubMedCrossRef
82.
Barnard KD, Skinner TC, Peveler R. The prevalence of co-morbid depression in adults with type 1 diabetes: systematic literature review. Diab Med. 2006;23:445–8.CrossRef
83.
Krebber AMH, Buffart LM, Kleijn G, Riepma IC, de Bree R, Leemans CR, Becker A, Brug J, van Straten A, Cuijpers P, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-Oncology. 2014;23:121–30.PubMedCrossRef
84.
Stubbs B, Vancampfort D, De Hert M, Mitchell AJ. The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis. Acta Psychiatr Scand. 2015;132:144–57.PubMedCrossRef
85.
Yang Y-L, Liu L, Wang Y, Wu H, Yang X-S, Wang J-N, Wang L. The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13:393.PubMedPubMedCentralCrossRef
86.
Amerio A, Stubbs B, Odone A, Tonna M, Marchesi C, Nassir Ghaemi S. Bipolar I and II Disorders; A Systematic Review and Meta-Analysis on Differences in Comorbid Obsessive-Compulsive Disorder. Iran J Psychiatry Behav Sci. 2016;10(3):e3604.
87.
Joffre-Velázquez VM, García-Maldonado G, Martínez-Perales G. Sald ívar-Gonzalez AgH: Revisión sistemática de la asociación entre sobrepeso, obesidad y enfermedad mental, conénfasis en el trastorno esquizofrénico. Rev colomb psiquiatr. 2009;38:705–16.
88.
Mcintyre R, Konarski J, Misener V, Kennedy S. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry. 2005;17:83–93.PubMedCrossRef
89.
Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord. 2002;70:19–26.PubMedCrossRef
90.
91.
Van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord. 2008;10:342–8.PubMedCrossRef
92.
De Hert M, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J. Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. Clin Pract Epidemiol Mental Health. 2006;2:14.CrossRef
93.
Laursen TM, Munk-Olsen T, Agerbo E, Gasse C, Mortensen PB. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry. 2009;66:713–20.PubMedCrossRef
94.
Vancampfort D, Mitchell AJ, De Hert M, Sienaert P, Probst M, Buys R, Stubbs B. Prevalence and predictors of type 2 diabetes mellitus in people with bipolar disorder: a systematic review and meta-analysis. J Clin Psychiatry. 2015;76:1490–9.PubMedCrossRef
95.
Vancampfort D, Mitchell AJ, De Hert M, Sienaert P, Probst M, Buys R, Stubbs B. Type 2 diabetes in patients with major depressive disorder: a meta-analysis of prevalence estimates and predictors. Depression Anxiety. 2015;32:763–73.PubMedCrossRef
96.
Yu M, Zhang X, Lu F, Fang L. Depression and risk for diabetes: a Meta-analysis. Can J Diabetes. 2015;39:266–72.PubMedCrossRef
97.
Petersen I, Lund C, Stein DJ. Optimizing mental health services in low-income and middle-income countries. Curr Opin Psychiatry. 2011;24:318–23.PubMedCrossRef
98.
Toftegaard KL, Gustafsson LN, Uwakwe R, Andersen UA, Becker T, Bickel GG, Bork B, Cordes J, Frasch K, Jacobsen BA, et al. Where are patients who have co-occurring mental and physical diseases located? Int J Soc Psychiatry. 2015;61:456–64.PubMedCrossRef
99.
Chereches RM, Litan CM, Zlati AM, Bloom JR. Does co-morbid depression impact diabetes related costs? Evidence from a cross-sectional survey in a low-income country. J Ment Health Policy Econ. 2012;15:127–38.PubMed
100.
Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manag. 2006;31:58–69.CrossRef
101.
Ren Y, Yang H, Browning C, Thomas S, Liu M. Prevalence of depression in coronary heart disease in China: a systematic review and meta-analysis. Chin Med J. 2014;127:2991–8.PubMed
102.
Abou Abbas L, Salameh P, Nasser W, Nasser Z, Godin I. Obesity and symptoms of depression among adults in selected countries of the Middle East: a systematic review and meta-analysis. Clin Obes. 2015;5:2–11.PubMedCrossRef
103.
Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BWJH, Zitman FG. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220–9.PubMedCrossRef
104.
Mannan M, Mamun A, Doi S, Clavarino A. Is there a bi-directional relationship between depression and obesity among adult men and women? Systematic review and bias-adjusted meta analysis. Asian J Psychiatr. 2016;21:51–66.PubMedCrossRef
105.
Gariepy G, Nitka D, Schmitz N. The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int J Obes (Lond). 2010;34:407–19.CrossRef
106.
Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, Rahman A. No health without mental health. Lancet. 2007;370:859–77.PubMedCrossRef
Metadata
Title
Co-morbidities of mental disorders and chronic physical diseases in developing and emerging countries: a meta-analysis
Authors
Labanté Outcha Daré
Pierre-Emile Bruand
Daniel Gérard
Benoît Marin
Valerie Lameyre
Farid Boumédiène
Pierre-Marie Preux
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-6623-6

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue

Research article

How did Ebola information spread on twitter: broadcasting or viral spreading?

Study protocol

Systematically testing the effects of promotion techniques on children’s fruit and vegetables intake on the long term: a protocol study of a multicenter randomized controlled trial

Research article

Clustering of lifestyle risk behaviours and its determinants among school-going adolescents in a middle-income country: a cross-sectional study

Research article

Health-related quality of life among people living with type 2 diabetes: a community based cross-sectional study in rural Nepal

Research article

Effects of socioeconomic status on risk of ischemic stroke: a case-control study in the Guangzhou population

Research article

Ready to participate? Using qualitative data to typify older adults’ reasons for (non-) participation in a physical activity promotion intervention